Prestige Consumer Healthcare (PBH) Cash from Financing Activities (2010 - 2025)

Prestige Consumer Healthcare has reported Cash from Financing Activities for 16 years, with the latest figure at -$6.7 million in Q4 2025.

• On a quarterly basis, Cash from Financing Activities rose 87.5% year-over-year to -$6.7 million in Q4 2025; TTM through Dec 2025 was -$129.5 million, a 45.84% increase from a year earlier, with the FY2025 full-year figure at -$182.1 million, up 24.45% from the prior year.
• Cash from Financing Activities was -$6.7 million for Q4 2025 at Prestige Consumer Healthcare, up from -$74.9 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $63.6 million in Q2 2021, with the low at -$83.7 million in Q1 2021.
• Average Cash from Financing Activities over 5 years is -$40.9 million, with a median of -$53.7 million recorded in 2023.
• The largest YoY upside for Cash from Financing Activities was 167.11% in 2021 against a maximum downside of 647.88% in 2021.
• Over 5 years, Cash from Financing Activities stood at -$67.6 million in 2021, then jumped by 85.18% to -$10.0 million in 2022, then tumbled by 547.07% to -$64.8 million in 2023, then grew by 16.93% to -$53.9 million in 2024, then surged by 87.5% to -$6.7 million in 2025.
• The last three Cash from Financing Activities figures came in at -$6.7 million (Q4 2025), -$74.9 million (Q3 2025), and -$36.3 million (Q2 2025), per Business Quant data.